Skip to content

Clinical trials

Suspended Phase 1 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Status: Suspended Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20202
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bellicum Pharmaceuticals1
DNAtrix, Inc.1
Envita Medical Center, Inc.1
H. Lee Moffitt Cancer Center and Research Institute1
M.D. Anderson Cancer Center1
Roger Williams Medical Center1
Rutgers, The State University of New Jersey1
Veana Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms8
Stomach Neoplasms2
Carcinoma, Intraductal, Noninfiltrating1
Carcinoma, Renal Cell1
Carcinoma, Squamous Cell1
Colonic Neoplasms1
Colorectal Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1
Liver Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.